PRESS RELEASE published on 07/10/2024 at 07:30, 1 year 11 months ago Viromed Medical AG seeks special approval for cold plasma device for the prevention of ventilator-associated pneumonia (VAP) Viromed Medical AG seeks special approval for cold plasma device to prevent ventilator-associated pneumonia (VAP). Study aims to revolutionize VAP treatment & reduce mortality Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Device VAP Prevention Special Approval
BRIEF published on 07/05/2024 at 17:35, 2 years ago Viromed Medical AG Announces Termination of Cooperation with terraplasma medical GmbH Termination Market Expansion Coopération Viromed Medical AG Cold Plasma Devices
BRIEF published on 07/05/2024 at 17:35, 2 years ago Viromed Medical AG annonce la fin de sa coopération avec terraplasma Medical GmbH Coopération L'expansion Du Marché Viromed Medical SA Résiliation Appareils À Plasma Froid
PRESS RELEASE published on 07/05/2024 at 17:30, 2 years ago EQS-Adhoc: Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH terminate their cooperation with immediate effect Viromed Medical AG terminates cooperation with terraplasma medical GmbH, allowing for expansion of sales potential with own cold plasma devices worldwide Viromed Medical AG Cold Plasma Devices Terraplasma Medical GmbH Cooperation Termination Sales Potential Expansion
BRIEF published on 04/22/2024 at 16:35, 2 years 2 months ago Viromed Medical AG Secures Exclusive Agreement with CORIUS Group for Plasma Care® Deployment Healthcare Partnership Viromed Medical AG CORIUS Group Plasma Care
BRIEF published on 04/22/2024 at 16:35, 2 years 2 months ago Viromed Medical AG conclut un accord exclusif avec le groupe CORIUS pour le déploiement de Plasma Care® Partenariat Soins De Santé Viromed Medical SA Groupe CORIUS Soins Du Plasma
PRESS RELEASE published on 04/22/2024 at 16:30, 2 years 2 months ago Viromed Medical AG reaches important milestone – agreement with CORIUS Group for exclusive use of Plasma Care® by Viromed with significant growth potential Viromed Medical AG reaches agreement with CORIUS Group for exclusive use of Plasma Care® with significant growth potential, establishing it as benchmark in Germany Viromed Medical AG CORIUS Group Cold Plasma Therapy Plasma Care® Clinical Alliance
BRIEF published on 04/22/2024 at 13:10, 2 years 2 months ago Viromed Medical AG Secures Exclusive Rights for Cold Plasma Therapy with CORIUS Group Medical Technology Earnings Growth Viromed Medical AG CORIUS Group Cold Plasma Therapy
BRIEF published on 04/22/2024 at 13:10, 2 years 2 months ago Viromed Medical AG obtient les droits exclusifs pour la thérapie par plasma froid avec le groupe CORIUS Technologie Médicale Croissance Des Bénéfices Viromed Medical SA Groupe CORIUS Thérapie Au Plasma Froid
PRESS RELEASE published on 04/22/2024 at 13:05, 2 years 2 months ago EQS-Adhoc: Viromed Medical AG concludes agreement with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care® – Additional earnings contribution of EUR 0.28 to EUR 0.34 per share expected Viromed Medical AG partners with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care®, expecting additional earnings contribution of EUR 0.28 to EUR 0.34 per share from 2025 onwards Earnings Contribution Viromed Medical AG CORIUS Group Cold Plasma Therapy Plasma Care®
Published on 07/06/2026 at 13:15, 8 minutes ago 55 North Mining Inc. Announces Name Change to "55 North Gold Inc." and Election of Two New Directors
Published on 07/06/2026 at 12:00, 1 hour 23 minutes ago Vanta to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 10:00 a.m. ET
Published on 07/06/2026 at 12:00, 1 hour 23 minutes ago Banyan Gold Expands High-Grade Domains at Powerline, AurMac Project, Yukon, Canada
Published on 07/06/2026 at 10:00, 3 hours 23 minutes ago Grande Portage Resources Reports Positive Results from Preliminary Strength Testing of Mine Backfill Materials
Published on 07/06/2026 at 09:05, 4 hours 18 minutes ago BioNxt Advances GLP-1 Sublingual Semaglutide ODF Program with Next Stage of Delivery Development Underway
Published on 07/06/2026 at 13:05, 18 minutes ago Tyron Birkmeir's Lurra Capital Backs LurraPay With $7 Million Investment
Published on 07/06/2026 at 12:10, 1 hour 13 minutes ago Tata Communications Strengthens India - Singapore Digital Corridor with AI-Ready Connectivity Investments
Published on 07/06/2026 at 12:02, 1 hour 21 minutes ago Aroundtown SA: Release of a capital market information
Published on 07/06/2026 at 12:00, 1 hour 23 minutes ago Envision Energy Partners with Pulse Clean Energy on 310 MWh BESS Project, Advancing Future Energy Systems for Next-Generation UK Energy Storage
Published on 07/06/2026 at 13:00, 23 minutes ago ALPOU - Groupe POULAILLON - Déclaration droits de vote
Published on 07/06/2026 at 10:59, 2 hours 24 minutes ago Statement of transactions in own shares from June 29, 2026 to July 3, 2026
Published on 07/06/2026 at 10:59, 2 hours 24 minutes ago Déclaration des transactions sur actions propres réalisées du 29/06/2026 au 03/07/2026